S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Allogene Therapeutics CFO Geoffrey Parker to Step Down

Geoffrey Parker, the longtime financial architect at Allogene Therapeutics, will retire on November 6, marking another significant shift in the company’s executive suite. The departure comes shortly after the biotechnology firm elevated former Chief Medical Officer Zachary Roberts to the role of president and chief executive officer.

Allogene Therapeutics CFO Geoffrey Parker to Step Down

Parker will maintain his oversight of the company’s financial operations through his final day in November. The San Francisco-based firm has initiated an external search to identify his successor as it navigates a broader leadership transition. This change follows the departure of David Chang, who stepped down after an eight-year tenure leading the organization. The transition reflects a new era for Allogene as the company reshapes its management structure under Roberts.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!